Thrombotic microangiopathy following onasemnogene abeparvovec for spinal muscular atrophy: A case series

Authors

Deepa H Chand, Washington University School of Medicine in St. Louis
Craig Zaidman, Washington University School of Medicine in St. Louis
Kapil Arya, University of Arkansas for Medical Sciences
Rachel Millner, University of Arkansas for Medical Sciences
Michelle A Farrar, University of New South Wales
Fiona E Mackie, University of New South Wales
Natalie L Goedeker, Washington University School of Medicine in St. Louis
Vikas R Dharnidharka, Washington University School of Medicine in St. Louis
Raja Dandamudi, Washington University School of Medicine in St. Louis
Sandra P Reyna, Novartis Gene Therapies

Journal

Journal of Pediatrics

Publication Date

4-1-2021

Volume

231

First Page

265

Last Page

268

Document Type

Open Access Publication

DOI

10.1016/j.jpeds.2020.11.054

Rights and Permissions

Chand DH, Zaidman C, Arya K, Millner R, Farrar MA, Mackie FE, Goedeker NL, Dharnidharka VR, Dandamudi R, Reyna SP. Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series. J Pediatr. 2021 Apr;231:265-268. doi: 10.1016/j.jpeds.2020.11.054 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Chand, Deepa H; Zaidman, Craig; Arya, Kapil; Millner, Rachel; Farrar, Michelle A; Mackie, Fiona E; Goedeker, Natalie L; Dharnidharka, Vikas R; Dandamudi, Raja; and Reyna, Sandra P, "Thrombotic microangiopathy following onasemnogene abeparvovec for spinal muscular atrophy: A case series." Journal of Pediatrics. 231, 265 - 268. (2021).
https://digitalcommons.wustl.edu/oa_4/398